Access Programs for Miglustat
Feb 17
2016
Drug Company Assistance
Actelion Pharmaceuticals US, Inc. has a for patients taking miglustat. At this time, however, the drug manufacturer does not have a program to help patients access the medication at reduced costs. If you know of such a program, please contact ASH Policy and Practice Associate, Katherine Stark.
Foundation Assistance
provides a range of resources for people diagnosed with Gaucher Disease. Please use their , email [email protected], or call 1-866-346-8176 for more information regarding eligibility and enrollment.
